Interventions for adhesive capsulitis: systematic review and network meta-analysis of randomised controlled trials

Objective To compare the benefits and harms of therapeutic interventions for adhesive capsulitis. Design Systematic review and network meta-analysis. Data Sources Medline, Cochrane Library, Embase, Web of Science, and Scopus were searched from inception to May 1, 2025, with an update in November 2025. Eligibility criteria for selecting studies Randomised controlled trials enrolling adults with adhesive capsulitis, comparing active treatment against another intervention, placebo, or usual care. Results A total of 189 randomised controlled trials involving 12,988 participants and 59 interventions were included. Most trials contributing to principal outcomes were at high risk of bias (71% for pain, 72% for function, and 71% for range of motion). At short-term follow-up, moderate-certainty evidence suggested that extracorporeal shockwave therapy probably reduced pain compared with usual care (mean difference [MD] −1.97 on a 0–10 scale, 95% confidence interval [CI] −2.97 to −0.97). Low-certainty evidence suggested may improve function (MD −11.42 on a 0–100 scale, 95% CI −16.68 to −6.15), although the direct and indirect estimates were importantly incoherent. For short-term range of motion, moderate-certainty evidence suggested that manipulation under anaesthesia combined with intra-articular steroid probably improved flexion (MD 33.29°, 95% CI 11.19° to 55.39°), as did manipulation under anaesthesia alone (MD 26.16°, 95% CI 8.19° to 44.13°). Low-certainty evidence suggested that extracorporeal shockwave therapy may improve flexion (MD 22.42°, 95% CI 12.99° to 31.84°) and abduction (MD 18.62°, 95% CI 8.09° to 29.14°), but both comparisons were limited by important incoherence. At mid-term follow-up, evidence for possible improvements in function with extracorporeal shockwave therapy and flexion with passive mobilisation was of low certainty, while evidence for pain reduction with extracorporeal shockwave therapy was of very low certainty. Most other comparative estimates were supported by low- or very-low-certainty evidence. Comparative safety remained highly uncertain because adverse events were incompletely and inconsistently reported; the absence of reported adverse events should not be interpreted as evidence of absence of harm. Conclusion Moderate-certainty evidence supports short-term pain reduction with extracorporeal shockwave therapy and improved short-term flexion with manipulation under anaesthesia, with or without intra-articular steroid. Most other treatment effects remain uncertain because of low certainty and incoherence, and comparative safety and mid-term effects are poorly established. The available evidence is mainly short term and outcome specific. Longer-term comparative effectiveness, overall benefits and harms, and applicability beyond predominantly primary adhesive capsulitis remain uncertain.